ARTEMIS DIANE T790M (An Amino Acid Substitution at Position 790 in EGFR, From a Threonine (T) to a Methionine (M)) Mutation at Hospital Laboratories in Comparison With Central Laboratory

CompletedOBSERVATIONAL
Enrollment

897

Participants

Timeline

Start Date

January 16, 2017

Primary Completion Date

June 29, 2018

Study Completion Date

June 29, 2018

Conditions
Locally Advanced or Metastatic EGFR(+) NSCLC Patients
Interventions
PROCEDURE

genomic testing of T790M mutation

patients will need to have genomic testing of T790M mutation at hospital laboratories and in central laboratory.

Trial Locations (31)

100021

Research Site, Beijing

110001

Research Site, Shenyang

130012

Research Site, Changchun

130021

Research Site, Changchun

150049

Research Site, Harbin

200032

Research Site, Shanghai

200433

Research Site, Shanghai

210029

Research Site, Nanjing

230001

Research Site, Hefei

264000

Research Site, Yantai

266071

Research Site, Qingdao

310003

Research Site, Hangzhou

310006

Research Site, Hangzhou

310009

Research Site, Hangzhou

310022

Research Site, Hangzhou

317000

Research Site, Linhai

330006

Research Site, Nanchang

430022

Research Site, Wuhan

430030

Research Site, Wuhan

450008

Research Site, Zhengzhou

510080

Research Site, Guangzhou

518020

Research Site, Shenzhen

610041

Research Site, Chengdu

650118

Research Site, Kunming

710061

Research Site, Xi'an

830000

Research Site, Ürümqi

830054

Research Site, Ürümqi

2501117

Research Site, Jinan

Unknown

Research Site, Beijing

Research Site, Xi'an

010017

Research Site, Hohhot

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY